Which of the Following Drug Strategies Would NOT Be Indicated

Which of the following drug strategies would NOT be indicated in conditions like deep vein thrombosis (DVT) ?

A) drugs that increase the ability of antithrombin to inhibit the activity of several clotting factors (e.g., heparin)
B) drugs that inhibit vitamin K metabolism in the liver (e.g., warfarin)
C) drugs that inhibit fibrinolysis (e.g., aminocaproic acid [Amicar], tranexamic acid [Cyklokapron])
D) drugs that directly inhibit the active form for clotting factor X (e.g., fondaparinux [Arixtra], rivaroxaban [Xarelto])
E) drugs that directly inhibit thrombin activity (e.g., lepirudin [Refludan], dabigatran [Pradaxa])